التفاصيل البيبلوغرافية
العنوان: |
New Developments in Insomnia Medications of Relevance to Mental Health Disorders |
المؤلفون: |
Krystal, Andrew D |
المصدر: |
Psychiatric Clinics of North America, vol 38, iss 4 |
بيانات النشر: |
eScholarship, University of California |
سنة النشر: |
2015 |
المجموعة: |
University of California: eScholarship |
مصطلحات موضوعية: |
Biomedical and Clinical Sciences, Clinical Sciences, Neurosciences, Sleep Research, Clinical Trials and Supportive Activities, Clinical Research, Brain Disorders, Mental Health, Good Health and Well Being, Adrenergic alpha-1 Receptor Antagonists, Antidepressive Agents, Antipsychotic Agents, Benzodiazepines, Histamine Antagonists, Humans, Mental Disorders, Orexin Receptor Antagonists, Receptors, Melatonin, Sleep Initiation and Maintenance Disorders, Personalization, Insomnia, Comorbid psychiatric disorders, Suvorexant, Doxepin, Prazosin, Eszopiclone, Medical and Health Sciences, Psychology and Cognitive Sciences, Psychiatry |
جغرافية الموضوع: |
843 - 860 |
الوصف: |
Many insomnia medications with high specificity have become available recently. They provide a window into the clinical effects of modulating specific brain systems and establish a new guiding principal for conceptualizing insomnia medications: "mechanism matters." A new paradigm for insomnia therapy in which specific drugs are selected to target the specific type of sleep difficulty for each patient includes administering specific treatments for patients with insomnia comorbid with particular psychiatric disorders. This article reviews insomnia medications and discusses the implications for optimizing the treatment of insomnia occurring comorbid with psychiatric conditions. |
نوع الوثيقة: |
article in journal/newspaper |
وصف الملف: |
application/pdf |
اللغة: |
unknown |
العلاقة: |
qt3466f1n5; https://escholarship.org/uc/item/3466f1n5Test |
الإتاحة: |
https://escholarship.org/uc/item/3466f1n5Test |
حقوق: |
public |
رقم الانضمام: |
edsbas.1FF3BFD8 |
قاعدة البيانات: |
BASE |